Skip to content
IdeaNotes

Zimbabwe Turns Down ‘Lopsided’ US Health Aid Package Due to Information Concerns

Health aid illustration
The proposed American funding was intended for initiatives for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has turned down a substantial American health deal valued at 367 million US dollars (272 million pounds) spanning five years over Washington's insistence on sensitive biological samples.

This rejection became public after a government memo dated December was leaked, indicating that President Emmerson Mnangagwa felt the deal was "lopsided".

An official spokesman later clarified that the United States was demanding access to genetic material for research and commercial gain while refused to guarantee the benefits from future treatments.

"We are forced to start the challenging and unfortunate process of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy indicated the United States had donated more than $1.9bn as health assistance to Zimbabwe over the last two decades.

A medical body in Zimbabwe has called for continued dialogue to find a deal acceptable to all parties so the country's vital HIV treatment initiative can continue.

Broader Background

Zimbabwe's decision comes after a comparable case in Kenya, where a high court blocked a related deal with the US following legal challenges were raised about the security of citizens' health data.

Since returning to office last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.

USAID had managed assistance for the US government, but Trump argued its expenditure was "inefficient" and his administration was pursuing direct bilateral agreements to enhance openness and accountability.

Based on reports, 16 African countries have so far signed these new health pacts, constituting over $18.3bn of fresh investment.

Details of the Declined Deal

The funds for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this collaboration might have yielded immense benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving HIV treatment via US-supported initiatives," Tremont added.

However, official spokesman Nick Mangwana said the arrangement was "unequal".

"Zimbabwe was being asked to surrender its genetic material and health information for a long time, with no equivalent guarantee of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that shared data," he stated.

"Put simply, our country would supply the raw materials for medical research without any assurance that the final treatments would be accessible to our citizens should a future disease outbreak arise."

Sovereignty and International Frameworks

He also said that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were disrupting structures already established through the international organization.

The spokesperson cited its Pandemic Benefit-Sharing system created to manage potential global health emergencies.

"This mechanism is designed to guarantee that when a nation provides its data, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to create them."

The government's concerns over the US deal "are not meant as hostility towards the US," Mangwana stressed.

"We encourage continued dialogue with our US partners on how subsequent collaboration might be arranged in a manner that honours the sovereignty and dignity of each country."

Health Experts Reaction

Medical experts said it understood the official position, but urged that talks should continue given that much of the country's HIV programmes were funded by international support.

"If technical issues exist, including those relating to information security or agreement terms, these can often be resolved via detailed discussion and mutually agreed protections," the group added.

The situation emphasises the ongoing challenges between accepting much-needed foreign assistance and safeguarding national sovereignty in an ever more data-driven world.

The writer

Terri Davis

Lena is a seasoned innovation consultant with over a decade of experience helping startups transform ideas into successful ventures.

IdeaNotes

Type to search articles.